Filing Flows › Health Care › Innovative Eyewear (LUCY)
Innovative Eyewear (LUCY) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 9, 2026 · Innovative Eyewear (LUCY) Q3 2026 earnings results →
Q3 2026 Revenue up 51% year over year to $1.0M · 227¢ of every $1 of revenue lost · operating margin -226.5%
Innovative Eyewear made $1.0M in Q3 2026 (+51% Y/Y): E-commerce channels $780K, Wholesale channels $223K, App store subscriptions $6K. Operating margin -226.5%, net loss $2.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 9, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.0M in Q3 2026, up 51% year over year and roughly flat from the previous quarter. E-commerce channels was the largest line at 77% of revenue. Wholesale channels added $198K year over year (up 766%), 58% of the total change.
Gross margin was 31.8%, down 4.9 points from Q3 2025. Operating costs exceeded revenue by $2.3M, an operating margin of -226.5%. Operating expenses grew 25% against revenue growth of 51%. The quarter ended with a net loss of $2.3M, wider than the previous quarter's $1.7M loss.
Operating cash flow was −$1.5M. Non-cash charges added back $22K of depreciation and amortization and $198K of share-based compensation. Working capital and other items added $519K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 9, 2026 | $1.0M | +51% | -226.5% | −$2.3M | −$1.5M |
| Q2 2026 | 10-Q | Aug 14, 2026 | $1.0M | +74% | -165.3% | −$1.7M | −$1.9M |
| Q1 2026 | 10-Q | May 14, 2026 | $774K | +70% | -298.5% | −$2.3M | −$2.5M |
| Q4 2025 | 10-K | Mar 25, 2026 | $960K | +39% | -194.8% | −$1.9M | −$1.4M |
| Q3 2025 | 10-Q | Nov 13, 2025 | $668K | +164% | -274.8% | −$1.8M | −$1.5M |
| Q2 2025 | 10-Q | Aug 14, 2025 | $579K | +88% | -363.6% | −$2.1M | −$2.1M |
| Q1 2025 | 10-Q | May 13, 2025 | $455K | +18% | -391.4% | −$1.8M | −$2.3M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
About Innovative Eyewear
We develop and sell cutting-edge smart eyewear – including prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses – that is designed to allow our customers to remain connected to their digital lives. Founded and headquartered in Miami, Florida, we were initially organized as a Florida limited liability company effective August 15, 2019. On March 26, 2020, we converted from a Florida limited liability company into a Florida corporation.
In its own words, from its 10-K, filed Mar 25, 2026.
Innovative Eyewear against its Ophthalmic Goods peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +51% against the peers' median +7%. Operating margin: -226.5% against the peers' median 4.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| LUCY Innovative Eyewear | Q3 2026 | $1.0M | +51% | -226.5% |
| ALC Alcon | Q2 2026 | $2.8B | +9% | 0.4% |
| BLCO Bausch & Lomb | Q3 2026 | $1.4B | +7% | 11.3% |
| COO Cooper Companies | Q3 FY26 | $1.1B | +0.6% | 20.8% |
| EYE National Vision Holdings | Q2 2026 | $499M | +2% | 4.3% |
| WRBY Warby Parker | Q3 2026 | $245M | +10% | 1.5% |
| STAA Staar Surgical | Q3 2026 | $83.4M | -12% | 6.5% |
| RXST RxSight | Q3 2026 | $24.6M | -19% | -75.3% |
Source: Innovative Eyewear 10-Q on SEC EDGAR · CIK 1808377 · Ophthalmic Goods
13F: who owns LUCY and who is buying
More on LUCY
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results